Imaging apoptosis in vivo using 124I-ANNEXIN V (cas 136107-94-3) and PET
-
Add time:09/06/2019 Source:sciencedirect.com
Abnormal regulation of apoptosis is an important pathogenic mechanism in many diseases including cancer. Techniques to assess apoptosis in living organisms are limited and, in the case of solid organs, restricted to histological examination of biopsy samples. We investigated the use of 124I-annexin V, which binds to phosphatidylserine (PS) on the surface of apoptotic cells, as a potential positron emission tomography (PET) radioligand for the noninvasive measurement of apoptosis in vivo. Annexin V and a similar-sized protein, ovalbumin, were directly labelled with 124I. We report the validation of 124I-annexin V in vitro and in an animal model of liver apoptosis that has not previously been used to test iodinated annexin V. Also, for the first time, we report metabolite analysis of 124I-annexin V and the correlation of 124I-annexin V uptake with apoptotic density (AD). Sixfold more 124I-annexin V was associated with Jurkat cells after apoptosis induction, indicating that PS binding by annexin V was preserved after iodination. 124I-ovalbumin did not demonstrate increased uptake in apoptotic cells. In normal BDF-1 mice, the radioligand was rapidly cleared, but some in vivo dehalogenation resulted in the accumulation of activity in the thyroid and stomach content. PET images demonstrated uptake of 124I-annexin V but not 124I-ovalbumin in apoptotic liver lesions. In vivo 124I-annexin V uptake, derived from PET images, correlated with histologically derived AD (r=.86, P<.01). These results demonstrate that 124I-annexin V is localised to anti-Fas-induced apoptosis, in contrast to 124I-ovalbumin, which did not show preferential uptake in the apoptotic liver.
We also recommend Trading Suppliers and Manufacturers of ANNEXIN V (cas 136107-94-3). Pls Click Website Link as below: cas 136107-94-3 suppliers
Prev:Discrimination between primary necrosis and apoptosis by necrostatin-1 in ANNEXIN V (cas 136107-94-3)-positive/propidium iodide-negative cells
Next:Structure of Sm25, an antigenic integral membrane glycoprotein of adult Schistosoma mansoni☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Discrimination between primary necrosis and apoptosis by necrostatin-1 in ANNEXIN V (cas 136107-94-3)-positive/propidium iodide-negative cells09/05/2019
- Anti-ANNEXIN V (cas 136107-94-3) antibodies: are they prothrombotic?09/04/2019
- Combination of copeptin, placental growth factor and total ANNEXIN V (cas 136107-94-3) microparticles for prediction of preeclampsia at 10–14 weeks of gestation09/03/2019
- Full Length ArticleStable thrombus formation on irradiated microvascular endothelial cells under pulsatile flow: Pre-testing ANNEXIN V (cas 136107-94-3)-thrombin conjugate for treatment of brain arteriovenous malformations09/02/2019
- Attenuating a sickle cell crisis with ANNEXIN V (cas 136107-94-3)09/01/2019
- ANNEXIN V (cas 136107-94-3) conjugated nanobubbles: A novel ultrasound contrast agent for in vivo assessment of the apoptotic response in cancer therapy08/31/2019
- 111In-DOTA-ANNEXIN V (cas 136107-94-3) for imaging of apoptosis during HSV1-tk/GCV prodrug activation gene therapy in mice with NG4TL4 sarcoma08/30/2019
- Original ArticleRelation of anti-ANNEXIN V (cas 136107-94-3) antibodies to disease manifestations and activity in Behҫet’s disease patients08/29/2019
- Original Research ReportRole of red blood cells “ANNEXIN V (cas 136107-94-3)” and platelets “P-selectin” in patients with thalassemia08/28/2019


